| Announce Date | 12/11/2025 |
| EPS Normalized Actual | $-0.00714 (Beat by $0.00286) |
| EPS GAAP Actual | $-0.00714 (Beat by $0.00286) |
| Revenue Actual | $2.9249E-5B |
| Revenue Surprise | Beat by $0.029249M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.00507017 |
| EPS GAAP Estimate | $0.00507017 |
| Revenue Estimate | $0.012574013B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2029 | 0.05645759 | 74.21 | 0.02581371 | 0.08174928 | 1 |
| Apr 2028 | 0.20923 | 20.03 | 0.20446 | 0.214 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.0109 | 0.00091379 | 2.9249E-5B | -37176.49% | -11.16M |
| FQ3 2025 (Jul 2025) | 0.01 | 0.01 | 0.033212B | 100% | 28.42M |
| FQ2 2025 (Apr 2025) | -0.0087 | -0.0087 | 0.004688B | -160.84% | 4.69M |
| FQ1 2025 (Jan 2025) | 0 | -0.00507017 | 4.0E-6B | -378900% | -12.57M |
| FQ4 2024 (Oct 2024) | -0.004 | -0.01398621 | 0.010903B | -40.49% | -0.28M |
| FQ3 2024 (Jul 2024) | 0 | 0 | 0B | NAN% | -15.16M |
| FQ2 2024 (Apr 2024) | 0.0462 | 0.0462 | 0.012228B | 100% | 12.23M |
| FQ4 2023 (Oct 2023) | 0.03 | 0.03 | 0.015318B | 100% | 15.32M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.00507017
Consensus Revenue Estimates
0.012574013B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | -0.01004188 | -- | -0.01004188 | -0.01004188 | 1 |
| FQ4 2026 (Oct 2026) | -0.01004188 | 208.55 | -0.01004188 | -0.01004188 | 1 |
| FQ3 2026 (Jul 2026) | -0.01004188 | 199.58 | -0.01004188 | -0.01004188 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ4 2026 (Oct 2026) | 0.01B | 99.45 | 0.01B | 0.01B | 1 |
| FQ3 2026 (Jul 2026) | 0.01B | -535.16 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.00998621 | 0.0109 | 0.00091379 | 8.38% |
| FQ3 2025 (Jul 2025) | 0 | 0.01 | 0.01 | 100% |
| FQ2 2025 (Apr 2025) | -0.0087 | -0.0087 | 100% | |
| FQ1 2025 (Jan 2025) | 0.00507017 | 0 | -0.00507017 | -INF% |
| FQ4 2024 (Oct 2024) | 0.00998621 | -0.004 | -0.01398621 | 349.66% |
| FQ3 2024 (Jul 2024) | 0 | 0 | 0 | NAN% |
| FQ2 2024 (Apr 2024) | 0.0462 | 0.0462 | 100% | |
| FQ4 2023 (Oct 2023) | 0.03 | 0.03 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.01B | $0B | $-11.16M | -38139.09% |
| FQ3 2025 (Jul 2025) | $0B | $0.03B | $28.42M | 85.57% |
| FQ2 2025 (Apr 2025) | $0B | $0B | $4.69M | 100% |
| FQ1 2025 (Jan 2025) | $0.01B | $0B | $-12.57M | -314250.33% |
| FQ4 2024 (Oct 2024) | $0.01B | $0.01B | $-0.28M | -2.58% |
| FQ3 2024 (Jul 2024) | $0.02B | $0B | $-15.16M | -INF% |
| FQ2 2024 (Apr 2024) | $0B | $0.01B | $12.23M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $0.02B | $15.32M | 100% |